Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

  • receive the eCopy two days prior to the printed edition.
  • can partake in our online MCQs.
  • can enter our online sports quiz. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

PSI investigating statutory complaint on Epilim supply

By Mindo - 06th Jan 2020 | 17 views

A statutory complaint has been made to the Pharmaceutical Society of Ireland (PSI) in relation to the supply of sodium valproate (Epilim) to a patient. Epilim is licensed in Ireland to treat epilepsy and bipolar disorder. If a woman becomes pregnant while taking the drug, her baby is at risk of serious birth defects and developmental disorders.

Two “matters” have been brought to the PSI’s attention in regard to the supply of Epilim to patients since March 2019.

“One of these was raised as a concern and the PSI is seeking observations from the relevant pharmacy on the matter,” a spokesperson told the Medical Independent (MI).

“The other was raised as a statutory complaint. The latter is still in deliberative process (which is confidential) and I am unable to provide any further details on it.”

In March 2019, the PSI informed MI it had received 13 “concerns” in relation to Epilim since April 2018. The information it received “indicated that supplies of valproate medicines have been made without the required alerts, educational material, or counselling by pharmacists”.

At the time, the spokesperson said it had followed-up on these concerns where specific information was provided.

During 2019, a reminder to pharmacists about the appropriate supply and counselling of patients receiving valproate was included in a PSI newsletter.

“The PSI is the appropriate body to which any person may provide information or make a complaint in relation to their concern about how they have been treated in a pharmacy and about a pharmacist’s care, behaviour, or practice. And the PSI will take the appropriate regulatory action,” according to its spokesperson 

In recent years, the Organisation for Anticonvulsant Syndrome Ireland has highlighted numerous instances of patients receiving ‘Epilim in a bag’ without any warning materials.

Leave a Reply

Latest Issue
medical news
The Medical Independent 19th May 2022

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read